# HAPPE Spine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/happe-spine

- Industry: Medical Devices & Equipment
- Headquarters: Holland, US
- Website: www.happeortho.com
- Total disclosed funding: $3.3M
- Latest round: Series A (Aug 13, 2021)
- Investors on record: 1

## About

HAPPE Spine, LLC specializes in advanced spinal fusion solutions, focusing on innovative technologies that enhance surgical outcomes for orthopedic procedures.Founded in 2018 in Holland, US, HAPPE Spine, LLC develops innovative spinal fusion devices, notably the INTEGRATE ®-C Fusion Device. The company has engaged in 4 investment deals, with its most recent funding round, a Series A, completed on August 13, 2021, raising USD 3.34 mn led by Genesis Innovation Group. Founder Ryan Roeder has extensive experience in the healthcare technology sector, contributing to the firm’s focus on spinal solutions.HAPPE Spine specializes in innovative spinal fusion solutions, with its flagship product being the INTEGRATE ® -C Fusion Device. This advanced interbody fusion cage integrates cancellous porosity with hydroxyapatite throughout its structure, facilitating bone ingrowth and enhancing biomechanical stability. The INTEGRATE ® -C is designed to address a variety of spinal pathologies, offering interconnected porous features for optimal healing and radiolucent properties for improved post-operative imaging. The device is available in multiple footprints, lordosis angles, and heights, allowing customization to meet the anatomical needs of patients. HAPPE Spine primarily serves orthopedic surgeons and hospitals in the United States and select international markets, providing solutions for spinal reconstruction and fusion procedures.HAPPE Spine generates revenue primarily through direct sales of its INTEGRATE ® -C Fusion Device to hospitals and surgical centers. The transaction structure typically involves B2B sales, where healthcare providers purchase the devices as part of their surgical instrument inventory. Pricing structures for the INTEGRATE ® -C may vary based on specific configurations and quantities ordered, reflecting the customizability of the product. The company’s focus on delivering biomechanically advanced materials positions it competitively in the spinal implant market, engaging with both large healthcare networks and independent surgical facilities.Following its Series A funding of USD 3.34 mn in August 2021, HAPPE Spine plans to launch an innovative interbody spinal fusion implant, focusing on completing final regulatory testing and obtaining 510k approval. The company aims to scale manufacturing operations to increase the production of implant and instrument inventory. Additionally, HAPPE Spine is considering expansion into new markets and geographic regions, though specific targets and timelines have not been detailed.

## Funding rounds

- Series A, Aug 13, 2021, $3.3M — Genesis Innovation Group

## Investors

- Genesis Innovation Group (https://capitalatlas.ai/funds/genesis-innovation-group) — Series A